Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1)

BACKGROUND: Most tumour response scoring systems for resected pancreatic cancer after neoadjuvant therapy score tumour regression. However, whether treatment-induced changes, including tumour regression, can be identified reliably on haematoxylin and eosin-stained slides remains unclear. Moreover, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssen, Boris V, van Roessel, Stijn, van Dieren, Susan, de Boer, Onno, Adsay, Volkan, Basturk, Olca, Brosens, Lodewijk, Campbell, Fiona, Chatterjee, Deyali, Chou, Angela, Doglioni, Claudio, Esposito, Irene, Feakins, Roger, Fuchs, Talia L, Fukushima, Noriyoshi, Gill, Anthony J, Hong, Seung-Mo, Hruban, Ralph H, Kaplan, Jeffrey, Krasinkas, Alyssa, Luchini, Claudio, Shi, Chanjuan, Singhi, Aatur, Thompson, Elizabeth, Velthuysen, Marie-Louise F, Besselink, Marc G, Verheij, Joanne, Wang, Huamin, Verbeke, Caroline, Fariña, Arantza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364538/
https://www.ncbi.nlm.nih.gov/pubmed/36331867
http://dx.doi.org/10.1093/bjs/znac350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364538/
https://www.ncbi.nlm.nih.gov/pubmed/36331867
http://dx.doi.org/10.1093/bjs/znac350

Ejemplares similares